Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hardy-Bessard, A.C
8  Ergebnisse:
OpenAccess-Volltexte X
englisch X
Personensuche X
?
1

Risk factors for Coronavirus Disease 2019 (COVID-19) severi..:

Lièvre, A ; Turpin, A ; Ray-Coquard, I...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2020.09.035.  , 2020
Link: https://serval.unil.ch/n..
 
?
2

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F ; Floquet, A ; Hardy-Bessard, A.C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ygyno.2020.06.491.  , 2020
Link: https://hal.science/hal-..
 
?
3

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F ; Floquet, A ; Hardy-Bessard, A.C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ygyno.2020.06.491.  , 2020
Link: https://hal.science/hal-..
 
?
4

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F ; Floquet, A ; Hardy-Bessard, A.C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ygyno.2020.06.491.  , 2020
Link: https://hal.science/hal-..
 
?
5

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F ; Floquet, A ; Hardy-Bessard, A.C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ygyno.2020.06.491.  , 2020
Link: https://hal.science/hal-..
 
?
6

Need for risk-adapted therapy for malignant ovarian germ ce..:

Derquin, F ; Floquet, A ; Hardy-Bessard, A.C...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ygyno.2020.06.491.  , 2020
Link: https://hal.science/hal-..
 
?
7

Gemcitabine-oxaliplatin combination for ovarian cancer resi..:

Ray-Coquard, I ; Weber, B ; Cretin, J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653739.  , 2009
Link: http://www.ncbi.nlm.nih...
 
?
8

Bevacizumab and platinum-based combinations for recurrent o..:

Pfisterer, Jacobus ; Shannon, Catherine M ; Baumann, Klaus...
http://eprints.gla.ac.uk/217571/7/217571.pdf.  , 2020
Link: http://eprints.gla.ac.uk..
 
1-8